TASHA BOLLIN: Open Payments
NPI 1982112066 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 30 payments from 11 companies in 2025. Trend: 2023 $1,082 · 2024 $610 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 8 | $144 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $75 |
| ABBVIE INC. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Abbott Laboratories | 3 | $57 |
| Lilly USA, LLC | 3 | $45 |
| TOLMAR, INC. | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
Products named: TRELEGY ELLIPTA, XIFAXAN, FREESTYLE LIBRE 3, AIRSUPRA, UBRELVY, VRAYLAR, JARDIANCE, JATENZO.
Industry payments across NC — which companies pay providers there.
